A B A B C Supplementary Fig. 8 Supplementary Fig. 9

Slides:

Advertisements

Similar presentations

Supplementary Figure S1.

Advertisements

Supplementary Figure 2 Anti-PD-L1 (avelumab) enhances CD8 activation and decreases CD4 to a greater extent than commercially available anti-PD-L1 blocking.

Fig. 1. Level of Mac-1 expression on naive and recently activated LCMV GP33–41-specific T cells from TCR 318 transgenic mice. (A and B) Splenocytes from.

Interleukin 12 Induces T-Cell Recruitment Into the Atherosclerotic Plaque by Xiaoyu Zhang, Alexander Niessner, Takako Nakajima, Wei Ma-Krupa, Stephen L.

Volume 144, Issue 3, Pages e1 (March 2013)

Supplementary Table 1: primer sequences

Role of γ/δ T cells in a patient with CD4+ CD3– lymphocytosis, hypereosinophilia, and high levels of IgE Ilan Bank, MDa,d, Avner Reshef, MDb, Miriam.

by Jacob Rachmilewitz, Gregory J

A B C D CD4+ CD8+ Control Isotype Ab Anti-TNFa Ab Control Isotype Ab

Supplementary Table 1: Antibodies used in this study

A B C Supplementary Figure 1 Group 1 Group 2 Group 3 #1 #2 #3 #4 #5 #6

Volume 11, Issue 3, Pages (September 1999)

CD44-Mediated Adhesiveness of Human Hematopoietic Progenitors to Hyaluronan Is Modulated by Cytokines by Stéphane Legras, Jean-Pierre Lévesque, Rachida.

Supplementary Figure 2 Secondary transplanted brain tumors from PASC1 express human GH. Immuno-fluorescence staining of brain sections from mice implanted.

by Éric Aubin, Réal Lemieux, and Renée Bazin

Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.

Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy by Fumihiko Tsushima, Sheng Yao, Tahiro Shin, Andrew Flies, Sarah.

Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression by Søren Skov, Klaus Rieneck,

A B C D E F Supplementary Fig. 1. Gating strategy for CD44+CD133+CD24+ B16 tumor initiating cells (TIC). Cells were gated on CD44. CD44 positive cells.

A B C D E F Supplementary Fig. 2. Gating strategy for CD44+CD24+ ID8agg tumor initiating cells (TIC). Cells were gated on CD44. CD44 positive cells were.

Volume 9, Issue 5, Pages (November 1998)

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.

Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases Zaruhi Hovhannisyan,

Volume 119, Issue 6, Pages (December 2000)

Jack F Bukowski, Craig T Morita, Michael B Brenner Immunity

R. Sommaggio, M. Pérez-Cruz, J.L. Brokaw, R. Máñez, C. Costa

Figure 2S (Supplementary Data)

Ananda W Goldrath, Michael J Bevan Immunity

Suppressive effect of CD39+CD73+ melanoma cells on T-cell proliferation, and reversion of this effect via treatment with the CD39-blocking antibody, CD39.

Fig. 4. Antitumor efficacy of ERY974 against various cancer types.

Volume 13, Issue 1, Pages (January 2006)

Volume 44, Issue 3, Pages (March 2016)

PD‐L1 silencing in antigen presenting DCs results in hyperactivated pro‐inflammatory TCRhigh CD8+ T cells. PD‐L1 silencing in antigen presenting DCs results.

Enhanced proliferation and cytokine production in DGKζ and Cbl-b deficient mice. Enhanced proliferation and cytokine production in DGKζ and Cbl-b deficient.

Volume 27, Issue 2, Pages (August 2007)

Jack F Bukowski, Craig T Morita, Michael B Brenner Immunity

Supplemental Figure untreated Rituximab Alemtuzumab

Figure S1. Representative gating of 7-hr suppression assay from one subject Teff with media alone (top row), Teff with activation beads but not Tregs (middle),

Targeting allergen to FcγRI reveals a novel TH2 regulatory pathway linked to thymic stromal lymphopoietin receptor Kathryn E. Hulse, PhD, Amanda J. Reefer,

Volume 44, Issue 3, Pages (March 2016)

Elevation of Intracellular Cyclic AMP in Alloreactive CD4+ T Cells Induces Alloantigen- Specific Tolerance That Can Prevent GVHD Lethality In Vivo Matthew.

Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells Matthieu Allez, Jens Brimnes, Iris Dotan, Lloyd.

NKG2D Blockade Prevents Autoimmune Diabetes in NOD Mice

Volume 29, Issue 6, Pages (December 2008)

Induction of MMP-13 expression by soluble human glucocorticoid-induced tumor necrosis factor receptor in fibroblast-like synovial cells S.J. Kim, M.S.,

The PbGAPDH G6 fragment interacts with recombinant CD68.

Volume 16, Issue 2, Pages (February 2002)

Volume 68, Issue 2, Pages (August 2005)

Cécile Bouneaud, Philippe Kourilsky, Philippe Bousso Immunity

T Cell–Mediated Elimination of B7.2 Transgenic B Cells

Adaptive immune responses and NK activity.

Volume 15, Issue 3, Pages (September 2001)

Volume 17, Issue 2, Pages (February 2009)

CD8+ T cells were immunomodulated and required for the efficacy of anti–4-1BB/anti–PD-1 combination treatment. CD8+ T cells were immunomodulated and required.

Thomas M. Schmitt, Juan Carlos Zúñiga-Pflücker Immunity

Volume 25, Issue 10, Pages (October 2017)

Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection Marc Beyer, MD, Holger Bartz, MD, Katharina Hörner,

Notch 1 Signaling Regulates Peripheral T Cell Activation

Patrizia Stoitzner, Christoph H

CD11bhighCD27high conventional NK cells are converted into MDSCs

Volume 126, Issue 5, Pages (May 2004)

CD4+ and CD8+ TILs express surface CD137.

Flow cytometry analysis of intracellular cytokine expression in control PBMC (left set of panels) and following either PMA-ionomycin activation (middle.

ALT-803 stimulates proliferation and activation of human NK cells and T cells in vitro. ALT-803 stimulates proliferation and activation of human NK cells.

DAC treatment alters immune cell composition and enhances cytokine production in the peritoneal lavage. DAC treatment alters immune cell composition and.

Volume 10, Issue 5, Pages (February 2015)

A Key Role of Leptin in the Control of Regulatory T Cell Proliferation

Volume 25, Issue 4, Pages (October 2006)

Volume 20, Issue 6, Pages (June 2004)

Expression of CAR, endogenous TCR, and target-cell receptors.

Presentation transcript:

A B A B C Supplementary Fig. 8 Supplementary Fig. 9 Supplementary Figure 8. MEDI6383 enhancement of human CD4 T cell proliferation (CFSE dilution) among CD3 enriched T cells. Activation conditions consist of a mixture of CD4 and CD8 T cells incubated with CD32A-expressing HEK cells for drug clustering and 10 ng/mL of anti-CD3 mAb clone OKT3 for sub-optimal TCR stimulation. Controls include the listed set of components minus those indicated in the legend in the figure. Supplementary Fig. 9 Alloreactive Human CD4+ T cells Alloreactive Human CD4+ T cells A A375 B A375 Number of Cells Number of Cells Isotype control Anti-OX40 clone ACT35 Isotype control Anti-OX40L clone 11C3.1 Supplementary Figure 9. Cell surface expression of OX40 and OX40L on A375 melanoma tumor cells and A375-alloreactive human CD4+ T cells. (A) OX40 and (B) OX40L expression as determined by flow cytometry using PE conjugated anti-human OX40 mAb clone Ber-ACT35 (Biolegend) or anti-human OX40L mAb clone 11C3.1 binding, respectively, of A375 alloreactive CD4 T cells or A375 melanoma cells used for implantation in NOD-SCID mice. Supplementary Fig. 10 A B C Supplementary Figure 10. Pharmacodynamic effects of MEDI6383 on absolute T and B cell numbers of rhesus monkeys. Effects of MEDI6383 on (A) circulating CD4 T cell absolute numbers, (B) circulating CD8 T cell absolute numbers, or (C) circulating B cell absolute numbers (cells/mL) expressed as a percentage of the mean of the pre-dose levels from days -21, -14, -7 and 0. Circulating CD4 and CD8 T cells were enumerated (cells/mL) by flow cytometry using trucount beads for cells stained for CD3 and either CD4 or CD8; circulating B cells were enumerated in a similar manner using trucount beads for cells stained for CD20.